These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26387433)

  • 1. Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions.
    Munoz FM; Eckert LO; Katz MA; Lambach P; Ortiz JR; Bauwens J; Bonhoeffer J
    Vaccine; 2015 Nov; 33(47):6441-52. PubMed ID: 26387433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of adverse events following immunization during pregnancy and the newborn period.
    Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB
    Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving global monitoring of vaccine safety: a survey of national centres participating in the WHO Programme for International Drug Monitoring.
    Letourneau M; Wells G; Walop W; Duclos P
    Drug Saf; 2008; 31(5):389-98. PubMed ID: 18422379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following immunization: is this time for the use of WHO causality assessment?
    Tafuri S; Gallone MS; Calabrese G; Germinario C
    Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global alignment of immunization safety assessment in pregnancy - The GAIA project.
    Bonhoeffer J; Kochhar S; Hirschfeld S; Heath PT; Jones CE; Bauwens J; Honrado Á; Heininger U; Muñoz FM; Eckert L; Steinhoff M; Black S; Padula M; Sturkenboom M; Buttery J; Pless R; Zuber P;
    Vaccine; 2016 Dec; 34(49):5993-5997. PubMed ID: 27751641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
    Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
    Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.
    MacDonald NE; Guichard S; Amarasinghe A; Balakrishnan MR;
    Vaccine; 2015 Nov; 33(48):6902-7. PubMed ID: 25617790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety reporting in developing country vaccine clinical trials-a systematic review.
    Muehlhans S; Richard G; Ali M; Codarini G; Elemuwa C; Khamesipour A; Maurer W; Mworozi E; Kochhar S; Rundblad G; Vuitton D; Rath B
    Vaccine; 2012 May; 30(22):3255-65. PubMed ID: 22406279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Immunization Safety Monitoring - Worldwide, 2010-2019.
    Salman O; Topf K; Chandler R; Conklin L
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(15):547-551. PubMed ID: 33857066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).
    Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E
    Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date.
    Davies HG; Bowman C; Watson G; Dodd C; Jones CE; Munoz FM; Heath PT; Cutland CL; Le Doare K
    Int J Gynaecol Obstet; 2023 Jul; 162(1):29-38. PubMed ID: 37194339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions.
    Kochhar S; Clarke E; Izu A; Emmanuel Kekane-Mochwari K; Cutland CL
    Vaccine; 2019 May; 37(22):2967-2974. PubMed ID: 31014963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.
    Cassidy C; MacDonald NE; Steenbeek A; Ortiz JR; Zuber PL; Top KA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2010-2016. PubMed ID: 27159639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
    Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
    Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.
    Top KA; Constantinescu CM; Laflèche J; Bettinger JA; Scheifele DW; Vaudry W; Halperin SA; Law BJ
    Vaccine; 2013 Nov; 31(48):5700-5. PubMed ID: 24099871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization.
    Stuurman AL; Sharan A; Jahagirdar S; Elango V; Riera-Montes M; Kashyap N; Biccler J; Poluru R; Arora N; Mathai M; Mangtani P; DeVlieger H; Anderson S; Whitaker B; Wong HL; Cutland C; Guillard Maure C;
    Vaccine X; 2021 Dec; 9():100123. PubMed ID: 34825164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction. Maternal immunization - Promises and concerns.
    Englund JA
    Vaccine; 2015 Nov; 33(47):6372-3. PubMed ID: 26263199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous nodules: an important adverse event following immunization.
    Silcock R; Crawford NW; Perrett KP
    Expert Rev Vaccines; 2019 Apr; 18(4):405-410. PubMed ID: 30808246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetrical and neonatal case definitions for immunization safety data.
    Chen RT; Moro PL; Bauwens J; Bonhoeffer J
    Vaccine; 2016 Dec; 34(49):5991-5992. PubMed ID: 27554535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.